CRYSTALLINE FORMS OF N-[2-(3-HYDROXY-3-METHYLBUTYL)-6-(2-HYDROXYPROPAN-2-YL)-2H-INDAZOL-5-YL]-6-(TRIFLUOROMETHYL)PYRIDINE-2-CARBOXAMIDE
Publication
EP3448847A1
Kind: A1
Mar 18, 2026
Applicants
Bayer Pharma Aktiengesellschaft
Inventors
THALER, Tobias, PLATZEK, Johannes, GUIMOND, Nicolas
IPC Classifications
C07D 401/12 20060101AFI20171103BHEP
A61K 31/4439 20060101ALI20171103BHEP
A61P 35/00 20060101ALI20171103BHEP
A61P 37/00 20060101ALI20171103BHEP
A61P 27/00 20060101ALI20171103BHEP
A61P 9/00 20060101ALI20171103BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR